Furthermore, the mean tumor volume of the OXA-based CRT group combined with XPF–ERCC1 blocker was smaller than that of the OXA-based CRT group (356 mm3,1121 mm3) in the HCT116 tumor (Figure 5D). This evidence concerns the gene ERCC4 and neoplasm.